GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verona Pharma PLC (GREY:VNAPF) » Definitions » Cyclically Adjusted Book per Share

Verona Pharma (Verona Pharma) Cyclically Adjusted Book per Share : $0.00 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Verona Pharma Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Verona Pharma's adjusted book value per share for the three months ended in Mar. 2024 was $0.468. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Verona Pharma's average Cyclically Adjusted Book Growth Rate was 10.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Verona Pharma was 12.50% per year. The lowest was 12.50% per year. And the median was 12.50% per year.

As of today (2024-05-25), Verona Pharma's current stock price is $0.76. Verona Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.00. Verona Pharma's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Verona Pharma was 5.98. The lowest was 0.89. And the median was 2.89.


Verona Pharma Cyclically Adjusted Book per Share Historical Data

The historical data trend for Verona Pharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verona Pharma Cyclically Adjusted Book per Share Chart

Verona Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.18 0.97 0.84 -

Verona Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.79 0.76 - -

Competitive Comparison of Verona Pharma's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Verona Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verona Pharma's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verona Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Verona Pharma's Cyclically Adjusted PB Ratio falls into.



Verona Pharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Verona Pharma's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.468/131.6000*131.6000
=0.468

Current CPI (Mar. 2024) = 131.6000.

Verona Pharma Quarterly Data

Book Value per Share CPI Adj_Book
201206 1.031 95.600 1.419
201212 0.685 97.300 0.926
201306 0.536 98.000 0.720
201312 0.458 99.200 0.608
201406 1.169 99.800 1.541
201412 0.971 99.900 1.279
201506 0.714 100.100 0.939
201512 0.399 100.400 0.523
201606 0.108 101.000 0.141
201609 0.000 101.500 0.000
201612 0.828 102.200 1.066
201703 0.000 102.700 0.000
201706 1.156 103.500 1.470
201709 1.087 104.300 1.372
201712 1.028 105.000 1.288
201803 0.876 105.100 1.097
201806 0.832 105.900 1.034
201809 0.807 106.600 0.996
201812 0.764 107.100 0.939
201903 0.720 107.000 0.886
201906 0.599 107.900 0.731
201909 0.470 108.400 0.571
201912 0.406 108.500 0.492
202003 0.303 108.600 0.367
202006 0.222 108.800 0.269
202009 0.428 109.200 0.516
202012 0.399 109.400 0.480
202103 0.372 109.700 0.446
202106 0.327 111.400 0.386
202109 0.350 112.400 0.410
202112 0.308 114.700 0.353
202203 0.263 116.500 0.297
202206 0.231 120.500 0.252
202209 0.494 122.300 0.532
202212 0.480 125.300 0.504
202303 0.576 126.800 0.598
202306 0.569 129.400 0.579
202309 0.549 130.100 0.555
202312 0.519 130.500 0.523
202403 0.468 131.600 0.468

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Verona Pharma  (GREY:VNAPF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Verona Pharma was 5.98. The lowest was 0.89. And the median was 2.89.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Verona Pharma Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Verona Pharma's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Verona Pharma (Verona Pharma) Business Description

Industry
Traded in Other Exchanges
Address
3 More London Riverside, London, GBR, SE1 2RE
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma. The company is engaged in pharmaceutical development.